T9G — Vidac Pharma Holding Cashflow Statement
0.000.00%
Last trade - 00:00- €26.08m
- €26.98m
Annual cashflow statement for Vidac Pharma Holding, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 5 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.407 | -0.643 | -1.27 |
| Depreciation | |||
| Non-Cash Items | 0 | 0.249 | 0.376 |
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.016 | -0.075 | 0.216 |
| Change in Accounts Receivable | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | -0.391 | -0.468 | -0.682 |
| Capital Expenditures | 0 | — | — |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 0 | 0.008 | 0 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | 0 | 0.008 | 0 |
| Financing Cash Flow Items | 0.028 | — | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.282 | 0.401 | 0.715 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0.123 | -0.089 | 0.026 |